Clinical Trial Update: the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase 1 clinical trial evaluating the safety and efficacy of HGI-001 Injection in transfusion-dependent beta-thalassemia, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• HGI-001 Injection

Snippet

Sponsor: Shenzhen Hemogen | Conditions: β-thalassemia | EARLY_Phase 1 | Status: RECRUITING